Clinical outcomes of virologically-suppressed patients with pre-existing HIV-1 drug resistance mutations switching to rilpivirine/emtricitabine/tenofovir disoproxil fumarate in the SPIRIT study

Danielle P. Porter*, Jonathan Toma, Yuping Tan, Owen Solberg, Suqin Cai, Rima Kulkarni, Kristen Andreatta, Yolanda Lie, Susan K. Chuck, Frank Joseph Palella Jr, Michael D. Miller, Kirsten L. White

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical outcomes of virologically-suppressed patients with pre-existing HIV-1 drug resistance mutations switching to rilpivirine/emtricitabine/tenofovir disoproxil fumarate in the SPIRIT study'. Together they form a unique fingerprint.

Medicine & Life Sciences